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Systemic inflammatory response syndrome
SIRS
a b s t r a c t
Histoplasma capsulatum periprosthetic knee infection has rarely been reported in the literature due to its
low frequency. Notwithstanding, it is important to keep it among the differential diagnoses to avoid
delays in treatment. The current report presents the case of infectious knee monoarthritis in an
immunocompetent patient after unicompartmental knee arthroplasty. The joint infection was accom-
panied by disseminated histoplasmosis, which initiated an autoimmune reaction, ensuing a systemic
inflammatory response syndrome. The management protocol used in this case was successful and
included staged arthroplasty reconstruction combined with chronic antifungal and steroid pharmaco-
therapy. Approximately 4 years after total knee arthroplasty revision, there were no clinical signs of
localized or systemic infection.
© 2019 Published by Elsevier Inc. on behalf of The American Association of Hip and Knee Surgeons. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).
Introduction
Histoplasma capsulatum is a dimorphic fungus endemic in many
countries. Within the United States, it is most prevalent in the
Mississippi and Ohio River valleys. Other endemic regions are
located in Latin America, Asia, and Africa [1,2]. It is usually
asymptomatic in immunocompetent hosts, but it canmanifest with
florid symptoms in immunocompromised patients.
Isolation of Histoplasma capsulatum can be achieved using
fungal specific special media such as Sabouraud agar. Incubation at
25C for 6-12 weeks is usually required. A definitive diagnosis re-
quires visualization of Histoplasma capsulatum microscopically in
its yeast phase after transformation from its initial mold phase. This
conversion is achieved by using enriched media (blood agar or
brain heart infusion agar) with cysteine incubated at 35C-37C.
Culture using these specific media is only performed if there is a
high suspicion of fungal infection.
There have been a handful of case reports on periprosthetic joint
infection (PJI) due to Histoplasma capsulatum [3-5]. In the current
article, we review the rare occurrence of an immune-mediated
systemic inflammatory response syndrome (SIRS) caused by His-
toplasma capsulatum knee PJI. Particularly, we address the chal-
lenges and pitfalls during the medical and surgical management of
this atypical joint infection.
Case history
Patient's consent was obtained for the purpose of publishing
this report. A 57-year-old immunocompetent white male under-
went a right medial unicompartmental knee arthroplasty in 2002.
The patient presented to our institution in October 2010 with acute
knee pain and swelling, which had progressivelyworsened over the
past months (Fig. 1). The patient had a past medical history of
kidney stones and vasculitis, as well as a past surgical history of left
ankle surgery, bilateral inguinal hernia repair, navel hernia repair,
kidney stone removal, and rectal fistula. The painwas accompanied
by fevers and a diffuse erythematous rash. The appearance of the
symptoms followed a visit to Ethiopiawhere the patient suffered an
illness associated with significant diarrhea, weight loss, fever, and
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skin rashes. The patient underwent knee joint aspiration, and the
culture of the sample obtained was positive for Histoplasma cap-
sulatum. Inflammatory markers were notably elevated: the eryth-
rocyte sedimentation rate (ESR) was 106 mm/h (the normal value
according to the Musculoskeletal Infection Society [MSIS] criteria is
<30 mm/h), C-reactive protein (CRP) was 67.50 mg/L (MSIS normal
is <10 mg/L), and the peripheral white blood cell count (WBC) was
14,000 cells/cm3. Furthermore, knee synovial fluid differential
showed elevated total nucleated cell count of 1800 cells/uL, neu-
trophils at 31%, lymphocytes at 41%, and macrophages at 28%. The
patient did not receive antibiotic or antifungal treatment before the
laboratory workup.
Anteroposterior and lateral radiographs of the right knee taken
in 2010 (approximately 8 years after implantation) demonstrated
unicompartmental knee arthroplasty with radiolucency around the
tibial component and varus collapse, in addition to a radiolucent
area around the femoral component suggesting loosening of the
components (Fig. 1).
Owing to the coexisting symptoms of rash and fever along with
elevated inflammatory markers, it was suspected that the patient
had disseminated histoplasmosis with associated periprosthetic
loosening and deep fungal infection. He was started on a dual agent
therapy with itraconazole and amphotericin B (for 2 weeks and 12
months, respectively) based on culture sensitivities. A formal irri-
gation and debridement of the knee with removal of the uni-
compartmental prosthesis and placement of an articulating cement
spacer made up of four 40-g bags of cement each mixed with 200
mg of amphotericin B and 1 g of vancomycin was performed. Sur-
gical fungal culture revealed one colony of Histoplasma capsulatum
and surgical pathology showed reactive synovium with marked
chronic inflammation and necrotic debris. This procedure was
intended to be the first stage of a two-stage reconstruction, with
the timing of the second stage relying on a positive response to the
systemic treatment. However, 3 months after the first-stage pro-
cess (resection), the patient developed increasing knee pain. Even
though Histoplasma capsulatum antigen was not detected on blood
cultures, he still had elevated ESR (116 mm/h) and CRP (76.6 mg/L)
levels. A knee aspirationwas performed, but the amount of synovial
fluid obtained was insufficient for analysis. With all available in-
formation, it was suspected that the periprosthetic knee infection
persisted. Therefore, the patient underwent a second irrigation and
debridement of the knee with antibiotic spacer exchange
(composed of 4 bags of cement mix containing 200 mg of
amphotericin B and 1 g of vancomycin per bag of cement) (Fig. 2).
After 11 months of systemic treatment, we proceeded with a
total knee arthroplasty revision (Fig. 3) based on clinical evaluation
and decreasing inflammatory markers (WBC [2300 cells/cm3] and
ESR [19 mm/h]) even though the high-sensitivity CRP level [6] was
16.34 mg/dL (of note, due to the systemic involvement, the CRP
level was unreliable). The patient was kept on antifungal therapy
for an additional 6 months (liposomal amphotericin B and pos-
aconazole) after hospital discharge to reduce the risk of PJI recur-
rence because no standard duration of treatment for fungal PJI is
generally accepted.
About 1.5 years after total knee revision, he presented with the
clinical hallmarks of a SIRS with no signs of disseminated histo-
plasmosis (ie, fever, malaise, anorexia, weight loss) based on
medical history and physical examination. A bronchoalveolar
lavage performed showed no fungal presence, and tests for Histo-
plasma capsulatum antigen in urine and serum were also negative.
Inflammatory markers were found elevated (CRP [111.8 mg/mL]
and ESR [101.0 mm/h]), but no source of sepsis was identified on
hematologic or radiological studies. The patient was admitted to a
high-dependency-level care for supportive treatment. Ultimately,
he improved on a treatment course including liposomal ampho-
tericin B and prednisone.
Five months later, the patient was readmitted to the hospital
due to the presence of episcleritis, epididymitis, diffuse arthralgias,
and skin rash. His prosthetic knee remained asymptomatic,
whereas his inflammatory markers were found elevated (CRP [85.5
mg/L] and ESR [121 mm/h]). Serum histoplasmosis antigen testing
remained negative, and the diagnosis of an autoimmune reaction
secondary to the previous histoplasmosis was made. The exclusion
of persistent disseminated histoplasmosis was made based on the
serum and urine antigen testing. The patient responded to a
Figure 1. Anteroposterior and lateral radiograph of the right knee taken in 2010
(approximately 8 years after implantation) demonstrating unicompartmental knee
arthroplasty with radiolucency around the tibial component and varus collapse, in
addition to a radiolucent area around the femoral component suggesting loosening of
the components.
Figure 2. Anteroposterior and lateral radiographs of the right knee showing the sec-
ond antifungal cement spacer (composed of 4 bags of cement mix containing 200 mg
of amphotericin B and 1 g of vancomycin per bag of cement) placed after explantation
of the initial spacer. Molds were used.
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continued course of liposomal amphotericin B and prednisone. His
antifungal suppression was continued with posaconazole for 3
years after total knee arthroplasty revision. At the most recent
follow-up visit, 3.8 years after knee reimplantation, the patient had
completed the antifungal treatment and continued immunosup-
pression with corticosteroids for his inflammatory response. His
knee remained clinically asymptomatic. The patient denies having
any fever and the range of motion of the right knee is 0-120 degrees
of flexion and non-painful. There is no clinical evidence of systemic
or local infection.
Discussion
Periprosthetic knee infection due to Histoplasma capsulatum is
rare (ranking 10th in the order of frequency among all fungal PJIs)
[4]. Plain radiographs can help identify chronic infections where
implant loosening becomes obvious [7]. Serology, joint aspiration,
and culture are necessary to make the diagnosis according to the
MSIS criteria [4,7]. Two-stage reconstruction for chronic PJI has
shown good success [5,7,8]. Nevertheless, the success rate of fungal
PJI treatment is lower than that observed when treating bacterial
PJIs [8]. To the best of our knowledge, there are no reports con-
cerning the success rates of two-stage revisions in patients with
Histoplasma capsulatum PJI [5].
Previous investigations have reported the use of amphotericin-
loaded cement spacers coupled with chronic systemic oral azole or
amphotericin for the treatment of fungal PJIs [8-10]. The recom-
mended antifungal treatment in a cement spacer includes 200 mg
of amphotericin B or 800mg of voriconazole or fluconazole per 40 g
of cement [8].
In relation to the use of amphotericin Beloaded cement spacers,
it is important to recognize its chemical pharmacokinetics. Its heat
stability characteristics (up to 170C) and availability in sterile
powder form make amphotericin B an ideal candidate for use in
cement spacers [11]. However, its elution profile has been shown to
be lacking in previous studies. Goss et al. [12] found no elution of
amphotericin B from Simplex bone cement (Stryker, Mahwah, NJ)
after 1 week in vitro. Marra et al. [11] showed undetectable serum
concentrations of amphotericin at 50 hours in vivowhenmixedwith
PALACOS bone cement (Biomet, Warsaw, IN). In contrast, the wound
drainage fluid had a maximal concentration of 3.2 mg/L. As such, the
elution profile of this antibiotic has yet to be determined [13].
Systemic treatment includes either oral fluconazole (400-800
mg/d) or intravenous amphotericin B (15-35 mg/d). Their use
ranges from 3 weeks to lifelong antifungal suppression [8]. After
the antifungal course, the timeline for prosthesis reimplantation
might vary, but it is common practice to keep an antifungal
impregnated spacer for a period of 4-6 weeks alongside systemic
antifungals [1,5,14]. This period is followed by another 2-6 weeks
free of systemic antibiotics during which time, the patient is re-
evaluated for any signs of ongoing infection [1,5].
Immunocompromised patients (those affected by chronic ste-
roid use, acquired immune deficiency syndrome, hematologic
malignancies, and transplant recipients and infants with immune
system immaturity) are disproportionately affected as they are
unable to develop an effective cell-mediated immunity against the
Histoplasma capsulatum organism; the importance of the cell-
mediated response has been previously highlighted [15].
Symptoms associated with disseminated histoplasmosis include
fever, malaise, anorexia, and weight loss. Laboratory studies usually
show nonspecific increases in ESR and CRP levels [15]. The definitive
diagnosis is based on bone marrow, pulmonary, and skin biopsy
cultures or positive stains using methenamine silver or periodic acid
schiff [15]. In patients with disseminated histoplasmosis, aggressive
treatment is required with removal of the source infection (when
possible) and long-term antifungal treatment. Antifungal treatment
recommendations and duration vary. Liposomal amphotericin B (for
1-2 weeks) followed by 1 year of itraconazole is most commonly
used, and this treatment is recommended until the absence of His-
toplasma capsulatum antigen in urine and serum [2].
SIRS is a clinical diagnosis that describes a host’s response to an
infectious or noninfectious cause [16]. Although autoimmune re-
actions may manifest in multiple ways, SIRS is characterized by
systemic inflammation and widespread tissue injury and may
present in a similar fashion to disseminated histoplasmosis. For a
SIRS diagnosis, a patient must be positive for at least 2 of the
following clinical variables: (1) temperature >38C or <35C, (2)
heart rate >90 beats/min, (3) respiratory rate >20 breaths/min or
PCO2 <32 mmHg, and (4) WBC >12,000 cells/mm3 or <4000 cells/
mm3 [17]. Treatment guidelines for SIRS include early lung-
protective ventilation and antibiotics with goal-directed therapy,
with a thorough search for source of infection and rapid identifi-
cation of causative organism for focused antibiotic treatment [18].
To the best of our knowledge, the current report is the first to
describe a Histoplasma capsulatum PJI complicated with an
autoimmune-induced SIRS. Failure of self-tolerance is a fundamental
part of the pathology of autoimmunity, and environmental and/or
infectious factors have long been postulated to trigger autoimmune
reactions [19]. There have been many mechanisms by which host
infection by a pathogen can cause autoimmunity, with 2 of the main
mechanisms including molecular mimicry and bystander activation
[19]. Molecular mimicry relates to the fact that a pathogenmay carry
antigens similar to the self-antigen, which causes activation of T and
B cells thereby leading to direct damage to self-tissue. Bystander
activation causes autoimmunity via epitome spreading whereby an
immune response directed to a pathogen causes damage to self-
tissue; antigen released by host tissue are uptaken by antigen pre-
senting cells, which initiates a self-specific immune response. As
such, disruption of the immune responses, checks, and balances can
lead to an autoimmune reaction [20].
This entity has not been widely described in the literature [21].
The clinical symptoms of disseminated histoplasmosis and the ones
of an autoimmune-induced SIRS reaction are similar; therefore, it is
important to consider an inclusive differential diagnosis when
Figure 3. Total knee arthroplasty revision with diaphyseal engaging press fit stems
and metaphyseal press fit sleeve on the tibia. Simplex P with tobramycin bone cement
(Stryker, Mahwah, NJ) was used on the implant surface.
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assessing a patient and consider autoimmune conditions as a cause
of SIRS [20,22]. To obtain a definitive diagnosis of disseminated
histoplasmosis, the organism must be isolated [15], and in the
absence of this, other etiologies must be explored. Our case was
unique because it was accompanied by a persistent systemic
inflammation, which made the serology unreliable while keeping
plausible the presence of a disseminated histoplasmosis infection
or an autoimmune-induced SIRS reaction. The management pro-
tocol used in this case was successful and included a staged
arthroplasty reconstruction combined with chronic antifungal and
steroid pharmacotherapies.
Summary
The current report describes the case of a Histoplasma capsu-
latum PJI complicated with an autoimmune-induced SIRS. The
treatment performed involved a staged arthroplasty reconstruction
combined with chronic antifungal and steroid pharmacotherapies.
Nearly 4 years after total knee reimplantation, the patient has
shown no clinical evidence of systemic or local infection.
Source of Funding: This research study did not receive any
specific grant from funding agencies in the public, commercial, or
not-for-profit sectors.
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